Chapter SPS 10

Chapter SPS 10

USE OF PHARMACEUTICAL AGENTS BY LICENSED OPTOMETRISTS

SPS 10.01   Authority.

SPS 10.02   Diagnostic pharmaceutical agents.

SPS 10.03   Therapeutic pharmaceutical agents.

Ch. SPS 10 Note Note: Chapter RL 10 was renumbered chapter SPS 10 under s. 13.92 (4) (b) 1., Stats., Register November 2011 No. 671. Chapter SPS 10 as it existed on January 31, 2020, was repealed and a new chapter SPS 10 was created effective February 1, 2020.

SPS 10.01 SPS 10.01 Authority. The rules in ch. SPS 10 are adopted under the authority in ss. 449.17 (1), 449.18 (6) (cm), and 961.39, Stats., to authorize the pharmaceutical agents for use by licensed optometrists in Wisconsin.

SPS 10.01 Note Note: To determine whether a licensed optometrist is eligible to use pharmaceutical agents under this chapter, refer to ch. Opt 6, relating to diagnostic and therapeutic pharmaceutical agents and removal of superficial foreign bodies from any eye or from an appendage to the eye.

SPS 10.01 History History: CR 19-028: cr. Register January 2020 No. 769, eff. 2-1-20.

SPS 10.02 SPS 10.02 Diagnostic pharmaceutical agents.

SPS 10.02(1) (1) A licensed optometrist, authorized in accordance with ch. Opt 6, may use topical ocular diagnostic pharmaceutical agents to determine the visual efficiency of the human visual system, including refractive and functional abilities, or to diagnose the presence of ocular disease or ocular manifestations of system disease and other departures from normal.

SPS 10.02(2) (2) Diagnostic pharmaceutical agents include:

SPS 10.02(2)(a) (a) Mydriatics.

SPS 10.02(2)(a)1. 1. Phenylephrine 2.5%.

SPS 10.02(2)(a)2. 2. Hydroxyamphetamine 1%.

SPS 10.02(2)(b) (b) Cycloplegics.

SPS 10.02(2)(b)1. 1. Tropicamide 1%.

SPS 10.02(2)(b)2. 2. Cyclopentolate 1%.

SPS 10.02(2)(c) (c) Topical anesthetics.

SPS 10.02(2)(c)1. 1. Benoxinate 0.4%.

SPS 10.02(2)(c)2. 2. Proparacaine 0.5%.

SPS 10.02(2)(c)3. 3. Tetracaine 0.5%.

SPS 10.02(2)(c)4. 4. Benoxinate 0.4% - Fluorescein 0.25% Combination.

SPS 10.02(2)(d) (d) Dyes.

SPS 10.02(2)(d)1. 1. Fluorescein 0.25% - Benoxinate 0.4% Combination.

SPS 10.02(2)(d)2. 2. Rose Bengal.

SPS 10.02(2)(e) (e) Miotics.

SPS 10.02(2)(e)1. 1. Dapiprazole HCl.

SPS 10.02(2)(e)2. 2. Pilocarpine 0.125%.

SPS 10.02(2)(f) (f) Any drug or device that is used for an ophthalmic diagnostic purpose and that is the subject of a new drug application approved by the food and drug administration under section 505 (c) (1) of the federal food, drug and cosmetic act, 21 USC 355, as amended.

SPS 10.02(2)(g) (g) Any drug or device that is used for an ophthalmic diagnostic purpose and that is generally exempt from the new drug application approval requirement contained in section 505 of the federal food, drug and cosmetic act, 21 USC 355, as amended.

SPS 10.02 History History: CR 19-028: cr. Register January 2020 No. 769, eff. 2-1-20; s. 35.17 correction in (2) (e) 2. made under s. 35.17, Stats., Register January 2020 No. 769.

SPS 10.03 SPS 10.03 Therapeutic pharmaceutical agents.

SPS 10.03(1) (1) A licensed optometrist, authorized in accordance with ch. Opt 6, may prescribe or administer a drug, as specified in sub. (2), for ocular therapeutic purposes.

SPS 10.03(2) (2) For the purposes of this chapter, therapeutic pharmaceutical agents are limited to:

SPS 10.03(2)(a) (a) Oral analgesics.

SPS 10.03(2)(a)1. 1. Acetaminophen.

SPS 10.03(2)(a)2. 2. Aspirin.

SPS 10.03(2)(a)3. 3. Salicylates.

SPS 10.03(2)(a)4. 4. Schedule III, IV and V narcotic analgesics.

SPS 10.03(2)(b) (b) Controlled substances in schedule II with limitations, as specified in s. 961.39 (2m), Stats.

SPS 10.03(2)(c) (c) Topical decongestant agents and decongestant combinations.

SPS 10.03(2)(c)1. 1. Epinephrine HCl.

SPS 10.03(2)(c)2. 2. Hydroxyamphetamine HBr.

SPS 10.03(2)(c)3. 3. Naphazoline HCl.

SPS 10.03(2)(c)4. 4. Oxymetazoline HCl.

SPS 10.03(2)(c)5. 5. Phenylephrine HCl.

SPS 10.03(2)(c)6. 6. Tetrahydrozoline HCl.

SPS 10.03(2)(c)7. 7. Combinations of the agents identified in subds. 1. to 6. with antihistamines or zinc sulfate.

SPS 10.03(2)(d) (d) Antiallergy agents.

SPS 10.03(2)(d)1. 1. Topical and oral antihistamine agents in the following drug categories:

SPS 10.03(2)(d)1.a. a. Alkyamines.

SPS 10.03(2)(d)1.b. b. Ethanolamines.

SPS 10.03(2)(d)1.c. c. Ethylenediamines.

SPS 10.03(2)(d)1.d. d. Phenothiazines.

SPS 10.03(2)(d)1.e. e. Piperazines.

SPS 10.03(2)(d)1.f. f. Piperidines.